{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:43:49Z","timestamp":1790534629900,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["N 2010PHT9NF-006"],"award-info":[{"award-number":["N 2010PHT9NF-006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbrc.2020.10.080","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T11:01:32Z","timestamp":1606561292000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy"],"prefix":"10.1016","volume":"538","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5370-7267","authenticated-orcid":false,"given":"Silvia","family":"Santopolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-4949","authenticated-orcid":false,"given":"M. Gabriella","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.10.080_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-micro-020518-115759","article-title":"Human Coronavirus: host-pathogen interaction","volume":"73","author":"Fung","year":"2019","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus\u2013host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.bbrc.2020.10.080_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/nsr\/nwaa036","article-title":"On the origin and continuing evolution of SARS-CoV-2","volume":"7","author":"Tang","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.bbrc.2020.10.080_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.bbrc.2020.10.080_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib8","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a Review","volume":"323","author":"Sanders","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.bbrc.2020.10.080_bib9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.10.080_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2020.10.080_bib11","series-title":"February, 2003, Lancet","first-page":"1353","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China","volume":"vol. 362","author":"Zhong","year":"2003"},{"key":"10.1016\/j.bbrc.2020.10.080_bib12","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/molbev\/msaa094","article-title":"Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense","volume":"37","author":"Xia","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.10.080_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.10.080_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.10.080_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.10.080_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.10.080_bib18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.chom.2020.08.002","article-title":"Approaches and challenges in SARS-CoV-2 vaccine development","volume":"28","author":"Dagotto","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbrc.2020.10.080_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.10.080_bib20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.10.080_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.10.080_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-020-0732-3","article-title":"Immune-mediated approaches against COVID-19","volume":"15","author":"Florindo","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein, Cell","volume":"17","author":"Xia","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.10.080_bib25","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2020.10.080_bib26","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.6505693","article-title":"Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens","volume":"226","author":"Alexander","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.10.080_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1034\/j.1600-0854.2000.010702.x","article-title":"Folding of viral envelope glycoproteins in the endoplasmic reticulum","volume":"1","author":"Braakman","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.bbrc.2020.10.080_bib28","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/514170","article-title":"Effects of glycosylation on the properties and functions of influenza virus hemagglutinin","volume":"176","author":"Schulze","year":"1997","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2020.10.080_bib29","article-title":"Role of the early secretory pathway in SARS-CoV-2 infection","volume":"219","author":"Sicari","year":"2020","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib32","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1128\/jvi.64.11.5367-5375.1990","article-title":"Assembly of coronavirus spike protein into trimers and its role in epitope expression","volume":"64","author":"Delmas","year":"1990","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0168-1702(91)90103-3","article-title":"Carbohydrate-induced conformational changes strongly modulate the antigenicity of coronavirus TGEV glycoproteins S and M","volume":"20","author":"Delmas","year":"1991","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2020.10.080_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0042-6822(81)90115-X","article-title":"Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein","volume":"115","author":"Holmes","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/jvi.40.2.350-357.1981","article-title":"Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin","volume":"40","author":"Rottier","year":"1981","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/jvi.44.3.804-812.1982","article-title":"Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins","volume":"44","author":"Stern","year":"1982","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib37","doi-asserted-by":"crossref","first-page":"15873","DOI":"10.1016\/S0021-9258(17)36339-1","article-title":"The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 of mouse hepatitis virus and the maturation of coronavirus particles","volume":"260","author":"Repp","year":"1985","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.10.080_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virol.2009.12.020","article-title":"Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein","volume":"399","author":"Ritchie","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib39","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1128\/JVI.01250-12","article-title":"Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus","volume":"86","author":"Fukushi","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrd708","article-title":"Targeting glycosylation as a therapeutic approach","volume":"1","author":"Dwek","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2020.10.080_bib41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1042\/BST20200505","article-title":"\u03b1-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19","volume":"48","author":"Williams","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2020.10.080_bib42","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1126\/science.291.5512.2364","article-title":"Intracellular functions of N-linked glycans","volume":"291","author":"Helenius","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.10.080_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2217\/fvl-2018-0008","article-title":"Post-translational modifications of coronavirus proteins: roles and function","volume":"13","author":"Fung","year":"2018","journal-title":"Future Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib44","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1128\/jvi.67.12.7394-7401.1993","article-title":"Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins","volume":"67","author":"Opstelten","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.10.080_bib46","series-title":"Conformational perturbation of SARS-CoV-2 spike protein using N-Acetyl Cysteine, a molecular scissor: a probable strategy to combat COVID-19","author":"Debnath","year":"2020"},{"key":"10.1016\/j.bbrc.2020.10.080_bib47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41594-020-0478-5","article-title":"A\u00a0thermostable, closed SARS-CoV-2 spike protein trimer","volume":"27","author":"Xiong","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.embor.7400311","article-title":"The human protein disulphide isomerase family: substrate interactions and functional properties","volume":"6","author":"Ellgaard","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2020.10.080_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.emboj.7601505","article-title":"ERp57 is essential for efficient folding of glycoproteins sharing common structural domains","volume":"26","author":"Jessop","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2020.10.080_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2005.10.044","article-title":"The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites","volume":"124","author":"Tian","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.10.080_bib51","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1152\/physrev.00050.2006","article-title":"In and out of the ER: protein folding, quality control, degradation, and related human diseases","volume":"87","author":"Hebert","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2020.10.080_bib52","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1038\/s41598-018-28172-9","article-title":"Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase ERp57","volume":"8","author":"Piacentini","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.10.080_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/322038","article-title":"Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2020.10.080_bib54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cgh.2005.12.020","article-title":"Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species","volume":"4","author":"Rossignol","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2020.10.080_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2020.10.080_bib57","doi-asserted-by":"crossref","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level","volume":"284","author":"Rossignol","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.10.080_bib58","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2008.11.037","article-title":"Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin","volume":"136","author":"Rossignol","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib59","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1128\/JVI.01213-13","article-title":"Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation","volume":"87","author":"La Frazia","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(06)68852-1","article-title":"Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial","volume":"368","author":"Rossignol","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2020.10.080_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2020.10.080_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.010","article-title":"A\u00a0screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs","volume":"114","author":"Cao","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2020.10.080_bib63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"Rossignol","year":"2016","journal-title":"J.\u00a0Infect. Public Health"},{"key":"10.1016\/j.bbrc.2020.10.080_bib64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2020.10.080_bib65","series-title":"Nitazoxanide and JIB-04 have broad-spectrum antiviral activity and inhibit SARS-CoV-2 replication in cell culture and Coronavirus pathogenesis in a pig model","author":"Son","year":"2020"},{"key":"10.1016\/j.bbrc.2020.10.080_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.aivir.2016.08.004","article-title":"Coronavirus spike protein and tropism changes","volume":"96","author":"Hulswit","year":"2016","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.bbrc.2020.10.080_bib67","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1073\/pnas.1608147113","article-title":"Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism","volume":"113","author":"Park","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.10.080_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12250-020-00212-7","article-title":"A\u00a0unique protease cleavage site predicted in the spike protein of the novel pneumonia coronavirus (2019-nCoV) potentially related to viral transmissibility","volume":"35","author":"Wang","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bbrc.2020.10.080_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2020.10.080_bib70","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.10.080_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004502","article-title":"Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner","volume":"10","author":"Burkard","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2020.10.080_bib72","series-title":"The furin cleavage site of SARS-CoV-2 spike protein Is a key determinant for transmission due to enhanced replication in airway cells","author":"Peacock","year":"2020"},{"key":"10.1016\/j.bbrc.2020.10.080_bib73","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.10.080_bib74","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1128\/JVI.00079-09","article-title":"Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide","volume":"83","author":"Madu","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2020.10.080_bib76","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.10.080_bib77","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A\u00a0multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2020.10.080_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101212","article-title":"Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1\/S2 Site","volume":"23","author":"Jaimes","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2020.10.080_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/002215549704500102","article-title":"Localization of endogenous furin in cultured cell lines","volume":"45","author":"Shapiro","year":"1997","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.bbrc.2020.10.080_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1073","article-title":"Furin-mediated protein processing in infectious diseases and cancer","volume":"8","author":"Braun","year":"2019","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib81","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/v11090837","article-title":"The proteolytic regulation of virus cell entry by furin and other proprotein convertases","volume":"11","author":"Izaguirre","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2020.10.080_bib82","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/rmv.1846","article-title":"Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif","volume":"25","author":"Luczo","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib83","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro1208","article-title":"Influenza: lessons from past pandemics, warnings from current incidents","volume":"3","author":"Horimoto","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib84","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.10.080_bib85","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A\u00a0human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.10.080_bib86","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib87","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1242\/dev.125.24.4863","article-title":"Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin","volume":"125","author":"Roebroek","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.bbrc.2020.10.080_bib88","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1128\/IAI.70.12.7136-7139.2002","article-title":"The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in\u00a0vivo","volume":"70","author":"Sarac","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2020.10.080_bib89","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/IAI.72.1.602-605.2004","article-title":"Protection against anthrax toxemia by hexa-D-arginine in\u00a0vitro and in\u00a0vivo","volume":"72","author":"Sarac","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2020.10.080_bib90","doi-asserted-by":"crossref","first-page":"108254","DOI":"10.1016\/j.celrep.2020.108254","article-title":"Furin inhibitors block SARS-CoV-2 spike protein cleavage to suppress virus production and cytopathic effects","volume":"33","author":"Cheng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2020.10.080_bib91","series-title":"Furin cleavage site Is key to SARS-CoV-2 pathogenesis","author":"Johnson","year":"2020"},{"key":"10.1016\/j.bbrc.2020.10.080_bib92","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(79)90321-0","article-title":"Fatty acid binding to vesicular stomatitis virus glycoprotein: a new type of post-translational modification of the viral glycoprotein","volume":"17","author":"Schmidt","year":"1979","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.10.080_bib93","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1038\/npjbcancer.2016.28","article-title":"Palmitoylation: a protein S-acylation with implications for breast cancer","volume":"2","author":"Anderson","year":"2016","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbrc.2020.10.080_bib94","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physrev.00032.2014","article-title":"The physiology of protein S-acylation","volume":"95","author":"Chamberlain","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2020.10.080_bib95","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/JVI.80.3.1280-1289.2006","article-title":"Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity","volume":"80","author":"Thorp","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2020.10.080_bib96","doi-asserted-by":"crossref","first-page":"32725","DOI":"10.1074\/jbc.M109.043547","article-title":"Role of spike protein endodomains in regulating coronavirus entry","volume":"284","author":"Shulla","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.10.080_bib97","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2012.02.015","article-title":"Replication of murine coronavirus requires multiple cysteines in the endodomain of spike protein","volume":"427","author":"Yang","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib98","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.virol.2014.07.035","article-title":"Palmitoylation of the Alphacoronavirus TGEV spike protein S is essential for incorporation into virus-like particles but dispensable for S-M interaction","volume":"464\u2013465","author":"Gelhaus","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib99","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.virol.2006.10.034","article-title":"Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion","volume":"360","author":"Petit","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2010.05.031","article-title":"Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein","volume":"405","author":"McBride","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.09.007","article-title":"Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected","volume":"395","author":"Akerstr\u00f6m","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2020.10.080_bib102","series-title":"The role of high cholesterol in age-related COVID19 lethality","author":"Wang","year":"2020"},{"key":"10.1016\/j.bbrc.2020.10.080_bib103","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2020.10.080_bib104","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2032009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2032009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:57:46Z","timestamp":1777377466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2032009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":104,"alternative-id":["S0006291X2032009X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.080","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}